Dangos 1 - 18 canlyniadau o 18 ar gyfer chwilio 'Ling Lin (57361)', amser ymholiad: 0.01e Mireinio'r Canlyniadau
  1. 1
    Discovery of therapeutic compounds targeting brain metastasis-associated tumor cells (MBMATCs) in high MBM-Index melanoma.

    Discovery of therapeutic compounds targeting brain metastasis-associated tumor cells (MBMATCs) in high MBM-Index melanoma. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Single cell RNA-seq and snRNA-seq profiling of the PTs (primary melanoma), ECMs (extracranial melanoma metastases) and MBMs (melanoma brain metastases) environments.

    Single cell RNA-seq and snRNA-seq profiling of the PTs (primary melanoma), ECMs (extracranial melanoma metastases) and MBMs (melanoma brain metastases) environments. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Marker genes in melanoma tumor cells across PT, ECM and MBM by sc/snRNA-seq.

    Marker genes in melanoma tumor cells across PT, ECM and MBM by sc/snRNA-seq. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    scRNA-seq and snRNA-seq profiling of 26 melanoma samples.

    scRNA-seq and snRNA-seq profiling of 26 melanoma samples. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    AXL and MITF signature genes.

    AXL and MITF signature genes. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    The MBM-Index showed no significant correlation with clinicopathological features.

    The MBM-Index showed no significant correlation with clinicopathological features. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Interaction between MBMATCs and the immune microenvironment.

    Interaction between MBMATCs and the immune microenvironment. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Pseudotime trajectory analysis of melanoma clusters Mela4 and Mela5.

    Pseudotime trajectory analysis of melanoma clusters Mela4 and Mela5. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Identification of therapeutic drugs with high drug sensitivity for brain metastasis-associated tumor cells (MBMATCs) and high-brain metastasis (MBM) index patients.

    Identification of therapeutic drugs with high drug sensitivity for brain metastasis-associated tumor cells (MBMATCs) and high-brain metastasis (MBM) index patients. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    The enriched pathway by all transcripts differentially expressed between MBMATCs and other tumor cells, and between MBM-High and MBM-Low groups.

    The enriched pathway by all transcripts differentially expressed between MBMATCs and other tumor cells, and between MBM-High and MBM-Low groups. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Immune landscape and CD8<sup>+</sup> T cell transition states in PTs, ECMs and MBMs.

    Immune landscape and CD8<sup>+</sup> T cell transition states in PTs, ECMs and MBMs. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Immune cells profiling in PTs, ECMs and MBMs.

    Immune cells profiling in PTs, ECMs and MBMs. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Identification of melanoma brain metastasis-associated tumor cell subpopulations (MBMATCs).

    Identification of melanoma brain metastasis-associated tumor cell subpopulations (MBMATCs). gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Samples & cell type composition in melanoma tumor cells.

    Samples & cell type composition in melanoma tumor cells. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Samples & cell type composition in sc/snRNA-seq.

    Samples & cell type composition in sc/snRNA-seq. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Tumor cell-specific transcriptomic features across PTs, ECMs and MBMs.

    Tumor cell-specific transcriptomic features across PTs, ECMs and MBMs. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Fluvastatin inhibits the migration of melanoma A375 cells in a wound healing assay.

    Fluvastatin inhibits the migration of melanoma A375 cells in a wound healing assay. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    The MBM-Index as an independent predictor of overall survival (OS) in melanoma.

    The MBM-Index as an independent predictor of overall survival (OS) in melanoma. gan Jingxin Zeng (18773484)

    Cyhoeddwyd 2025
    Awduron Eraill: “...Ling Lin (57361)...”
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: